Consequently, stable cell lines can lead to reduced costs and faster market access for viral vector-based gene therapies, explains Abate. Important quality challenge ...

Presentation Details: Poster title: A Robust and Scalable Platform Process for GMP Manufacturing of Lentiviral Vectors Abstract #: 1152 Session title: Vector Product Engineering, Development, or ...

Large-scale production of gene therapeutics comprising equine infectious anaemia virus (EIAV) -based lentiviral vectors (LVs) would benefit from the development of producer cell lines enabling the ...

Current vector production cell lines and genetic manipulation techniques are too costly for large-scale manufacturing, according to new research. The study, ...